The Role of Certain Polymorphic Variants in Genes, Previously Associated with Blood Pressure Values, with Reference to the Risk of Development of Coronary Artery Disease
By:
References
- 1. Petrunak E, De Vore N, Porubsky P, Scott E. Structures of Human Steroidogenic Cytochrome P45017A1 with Substrates. J Biological Chemistry. 2014; 289: 32952-64.
- 2. Naessen T, Sjogren U, Bergquist J, et al. Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women. J Clin Endocrinol Metab. 2010; 95: 1889-97.
- 3. Malkin C, Pugh P, Morris P, et al. Low serum testosterone and increased mortality in men with coronary heart disease. Heart. 2010; 96; 1821-5.
- 4. Arsenault B, Lemieux I, Despre’s J, et al. The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: Results from the EPIC-Norfolk prospective population study. CMAJ. 2010; 182: 1427-32.
- 5. Maturana M, Breda V, Lhullier F, et al. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. Metabolism. 2008; 57: 961-5.
- 6. Jin H, Lin J, Fu L, et al. Physiological testosterone stimulates tissue plasminogen activator and tissue factor and inhibis plasminogen activator inhibitor type 1 release in endothelial cells. Biochem Cell Biol. 2007; 85(2): 246-51.
- 7. Kourtidis A, Anastasiasdis P. PLEKHA7 defines an apical junctional complex with cytoskeletal associations and miR- NA-mediated growth implications. Cell Cycle. 2016; 15(4): 498-505.
- 8. Guerra D, Shah J, Vasileva E, et al. PLEKHA7 Recruits PD=D11 to Adherens Junctions to Stabilize Nectins. The Journal of Biological Chemistry. 2016; 291; 11016-29.
- 9. Goeller G, De Marco S, Strehler E. Characterization of PISP, a novel single-PDZ protein that binds to all plasma membrane Ca2+ -ATPase b-splice variants. Ann NY Acad Sci. 986; 461-71.
- 10. Lyon C, Koutsouki E, Aguilera C, et al. Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis. J Vasc Surg. 2010; 52(5): 1301-9.
- 11. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16:1215.
- 12. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart Journal. 2013; 34: 2949-3003.
- 13. Thygesen K, Alpert J, Jaffe A, et al. Third universal definition of myocardial infarction. Circulation. 2012; 126: 2020-35.
- 14. Standards of Medical Care in Diabetes – 2017. American Diabetes Association. The Journal of Clinical and Applied Research and Education. 2017; 40: suppl 1.http://care.diabetesjournals.org/content/diacare/suppl/2016/12/15/40.SupplementB1.DC1/DCB40BS1Bfinal.pdf
- 15. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34: 2159-2219.
- 16. Reiner Z, Catapano A, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidemias. Eur Heart J. 2011; 32: 1769-1818.
- 17. Petraco R, van de Hoef T, Nijjer S, et al. Baseline Instantaneous wave-free ratio as a pressure – only estimation of underlying coronary flow reserve. Circ Cardiovasc Interv. 2014; 7: 492-502.
- 18. Yonetsu T, Murai T, Kanaji Y et al. Significance of microvascular function in visual – functional mismatch between invasive coronary angiography and fractional flow reserve. J Am Heart Assoc. 2017; 6: e005916.
- 19. Peden J, Farrall M. Thirty-five common variants for coronary artery disease: the fruits of a much collaborative labor. Hum Mol Genet. 2011; 20(R2): R198-R205.
- 20. Schunkert H, König I, Kathiresan S, et al. Large-scale association analyses identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011; 43: 333–8.
- 21. The International Consortium for Blood Pressure Genome-Wide Association Studies. Genetic Variants in Novel Pathways Influence Blood Pressure and Cardiovascular Disease Risk. Nature. 2012; 478(7367): 103-109.
- 22. Dai Ch, Xie X, Ma Y, et al. Haplotype analyses of CYP17A1 genetic polymorphisms and coronary artery disease in a Uygur population. Journal of the Renin-Angiotensin-Aldosterone System. 2015; 16(2); 389-98.
- 23. Schunkert H, König I, Kathiresan S, et al. Large-scale association analyses identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 43(4): 333-8.
- 24. Roberts R, Stewart A. Genes and Coronary Artery Disease: Where Are We? J Am Coll Cardiol. 2012; 60: 1715-21.
- 25. The IBC 50K CAD Consortium. Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease. PLoS Genet. 2011; 7(9): e1002260.
- 26. Butterworth AS, Braund P, Farrall M. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet. 2011;7:e1002260.
- 27. Chuan-Fang Dai 2015, Relationship between CYP17A1 genetic polymorphism and coronary artery disease in a Chinese Han population. Lipids Health Dis. 2015; 14; 16.doi: 10.1186/s12944-015-0007-4.
- 28. Zhang N, Jia J, Ding 4 et al. Common variant rs11191548 near the CYP17A1 gene is associated with hypertension and the serum 25 (OH) D levels in Han Chinese. J Hum Genet. 2018; 63: 731-7.
- 29. Wu L, Gao L, Zhao X, et al. Associations of the hypertension-related single nucleotide polymorphism rs11191548 with high-density lipoprotein cholesterol and leptin in Chinese children. BMC Med Genet. 2018; 19(1): 9.
- 30. Kourtidis A, Anastasiasdis P. PLEKHA7 defines an apical junctional complex with cytoskeletal associations and miRNA-mediated growth implications. Cell Cycle. 2016; 15(4): 498-505.
- 31. Guerra D, Shah J, Vasileva E, et al. PLEKHA7 Recruits PDZD11 to Adherens Junctions to Stabilize Nectins. The Journal of Biological Chemistry. 2016; 291; 11016-29.
- 32. Lin Y, Lai X, Chen B, et al. Genetic variations in CYP17A1, CACNB2 and PLEKHA7 are associated with blood pressure and/or hypertension in She ethnic minority of China. Atherosclerosis. 2011; 219(2): 709-14.
- 33. Mancia G, Grassi G, Redon J. Manual of Hypertension of the European Society of Hypertension, Second Edition. Taylor Francis Group. LLC, 2014.
- 34. Hong K, Jin H, Lim J, et al. Recapitulation of two genomewide association studies on blood pressure and essential hypertension in the Korean population. J Hum Genet. 2010: 55(6): 336-41.
- 35. Hayakawa H, Raij L. Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension. J Hypertens. 1999; 17(5): 611-9.
- 36. Elbekai R, El-Kadi A. Cytochrome P450 enzymes: Central players in cardiovascular health and disease. Pharmacol Ther 2006; 112: 564–87.
- 37. Kurita S, Yamada T, Rikitsu E, et al. Binding between the junctional proteins afadin and PLEKHA7 and implication in the formation of adherens junction in epithelial cell. J Biol Chem. 2013; 288(41): 29356-68.
- 38. Kayima J, Liang J, Natanzon Y, et al. Association of genetic variation with blood pressure traits among East Africans. Clin Genet. 2017; 92(5): 487-94.
- 39. Morrison A, Bis J, Hwang Sh, et al. Sequence analysis of six blood pressure candidate regions in 4,178 individuals: the Cohorts for Heart and Aging Reseaech in Genomic Epidemiology (CHARGE) targeted sequencing study. PLoS One. 2014; 9(10): e109155.
- 40. Levy D, Ehret G, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009; 41(6): 677-87.
- 41. Wain L, Verwoert G, O-Reilly P, et al. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet. 2011; 43(10): 10005-11.
- 42. Maas A, Appelman Y. Gender differences in coronary heart disease. Neth Heart J. 2010; 18(12); 598-602.
- 43. Kim E, Menon V. Status of women in cardiovascular clinical trials. Arterioscler Thromb Vasc Biol. 2009; 29: 279-83.
- 44. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J. 2013; 34: 2949-3003.
- 45. Thygesen K, Alpert J, Jaffe A, et al. Third universal definition of myocardial infarction. Circulation. 2012; 126: 2020-35.
- 46. Leon B, Maddox Th. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. Workd J Diabetes. 2015; 6(13); 1246-58.
- 47. Miller M. Dyslipidemia and cardiovascular risk: the importance of early prevention. QIJM: An International Journal of Medicine. 2009; 102(9); 65-67.
- 48. https://www.escardio.org/staticBfile/Escardio/Subspecialty/EACPR/Documents/score-charts.pdf access on 01.10.2020.
- 49. Mega J, Stitziel N, Smith J, et al. Genetic Risk, Coronary Heart Disease Events, and the Clinical Benefit of Statin Therapy. Lancet. 2015; 385(9984): 2264-71.
Language: English
Page range: 5 - 11
Submitted on: May 30, 2022
Accepted on: Aug 12, 2022
Published on: Feb 10, 2023
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2023 T. Yaneva-Sirakova, R. Kaneva, R. Tzveova, R. Bozhilova, I. Popov, M. Shumkova, I. Hristova, D. Vassilev, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.